EMPA-REG Outcome: results that question

被引：0
|
作者：
Pouchain, Denis [1 ]
机构：
[1] UFR Tours, Dept Univ Med Gen, Tours, France
来源：
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE | 2016年 / 27卷 / 128期
关键词：
Empagliflozin; Hypoglycemic agents; Randomized controlled trials;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：278 / 282
页数：5
相关论文
共 50 条
  • [31] Effect of empagliflozin on heart failure outcomes in subgroups by age: results from EMPA-REG OUTCOME
    Monteiro, P.
    Schaper, N.
    Clark, D.
    Hantel, S.
    Woerle, H. J.
    Inzucchi, S. E.
    Fitchett, D.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1191 - 1192
  • [32] Effect of Empagliflozin on Heart Failure Outcomes in Subgroups by Age: Results from EMPA-REG Outcome
    Monteiro, Pedro
    Schaper, Nicolaas
    Clark, Douglas
    Hantel, Stefan
    Woerle, Hans J.
    Inzucchi, Silvio E.
    Fitchett, David
    DIABETES, 2016, 65 : A291 - A291
  • [33] EFFECT OF EMPAGLIFLOZIN ON HEART FAILURE OUTCOMES IN SUBGROUPS BY AGE: RESULTS FROM EMPA-REG OUTCOME
    Lee, Dae Wook
    Monteiro, Pedro
    Clark, Douglas
    Hantel, Stefan
    Woerle, Hans J.
    Inzucchi, Silvio E.
    Fitchett, David
    JOURNAL OF HYPERTENSION, 2016, 34 : E520 - E520
  • [34] Effect of empagliflozin on heart failure outcomes in subgroups by age: results from EMPA-REG OUTCOME
    Monteiro, P.
    Schaper, N.
    Clark, D.
    Hantel, S.
    Woerle, H. -J.
    Inzucchi, S. E.
    Fitchett, D.
    DIABETOLOGIA, 2016, 59 : S534 - S534
  • [35] EMPA-REG OUTCOME: A Milestone in the Treatment of the Diabetes mellitus Type 2?
    Schneider, C. A.
    Pfuetzner, A.
    DIABETES STOFFWECHSEL UND HERZ, 2015, 24 (06): : 405 - 407
  • [36] Relationship between Hypoglycaemia (Hypo), Outcomes and Empagliflozin (EMPA) Treatment Effect in EMPA-REG OUTCOME
    Zinman, Bernard
    Fitchett, David H.
    Mattheus, Michaela
    Wanner, Christoph
    George, Jyothis T.
    Vedin, Ola
    Inzucchi, Silvio E.
    Johansen, Odd Erik
    DIABETES, 2019, 68
  • [37] Understanding EMPA-REG OUTCOME (vol 3, pg 928, 2015)
    Muskiet, M. H. A.
    van Raalte, D. H.
    van Bommel, E. J. M.
    Smits, M. M.
    Tonneijck, L.
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (02): : E2 - E2
  • [38] The interim experts' counsil resolution on the EMPA-REG OUTCOME trial issues
    不详
    DIABETES MELLITUS, 2016, 19 (02): : 181 - 184
  • [39] Empagliflozin in Resistant Hypertension: Findings From the Empa-reg Outcome Trial
    Ferreira, Joao Pedro
    Fitchett, David
    Ofstad, Anne Pernille
    Kraus, Bettina J.
    Wanner, Christoph
    Zwiener, Isabella
    Lauer, Sabine
    George, Jyothis T.
    Rossignol, Patrick
    Zannad, Faiez
    CIRCULATION, 2019, 140
  • [40] EMPA-REG OUTCOME和LEADER试验带来的思考
    严晓伟
    浙江医学, 2016, 38 (24) : 1955 - 1956
12345